Updated time: 2023-04-11 10:15:54
28A-1100225
2021-07-02
TW I778596、US 11,506,664 B1
The search of alternative approaches to epithelial cell adhesion molecule (EpCAM), for the isolation of circulating tumor cells (CTC), is on the rise. This work attempts at evaluating the feasibility of using a new glycosaminoglycan as a probe to isolate CTCs from the peripheral blood of 65 advanced/metastatic cholangiocarcinoma (CCA) patients. The positive enrichment of CTCs from 1 mL of blood using octasaccharide-bound magnetic beads and subsequent staining on an integrated microfluidic platform is demonstrated.
- The modules of integrated microfluidic system were integrated with micro-mixers, micro-pumps, micro-channels, normally-closed microvalves and waste outlets
- The developed system could process blood pretreatment, CTC capturing and immunofluorescence staining on a single chip
- The new octasaccharide has extremely high specificity for cholangiocarcinoma cells
- Carbohydrate synthesis
- Analysis of carbohydrates
- Purification of saccharide compounds
- Cancer diagnosis and treatment development

Fig1. Schematics of the on-chip circulating tumor cell (CTC) isolation and detection process.

Fig2. Results of cell spiking experiments.
Shang-Cheng Hung、Gwo-Bin Lee、Priya Gopinathan
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

A Novel Octasaccharide Probe for Detection of Cholangiocarcinoma Cells